BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Arden C. A role for Glucagon-Like Peptide-1 in the regulation of β-cell autophagy. Peptides 2018;100:85-93. [PMID: 29412836 DOI: 10.1016/j.peptides.2017.12.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Graham GV, Mccloskey A, Abdel-wahab YH, Conlon JM, Flatt PR. A long-acting, dual-agonist analogue of lamprey GLP-1 shows potent insulinotropic, β-cell protective, and anorexic activities and improves glucose homeostasis in high fat-fed mice. Molecular and Cellular Endocrinology 2020;499:110584. [DOI: 10.1016/j.mce.2019.110584] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
2 Musale V, Abdel-wahab YHA, Flatt PR, Conlon JM, Mangoni ML. Insulinotropic, glucose-lowering, and beta-cell anti-apoptotic actions of peptides related to esculentin-1a(1-21).NH2. Amino Acids 2018;50:723-34. [DOI: 10.1007/s00726-018-2551-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
3 Zummo FP, Krishnanda SI, Georgiou M, O'Harte FP, Parthsarathy V, Cullen KS, Honkanen-Scott M, Shaw JA, Lovat PE, Arden C. Exendin-4 stimulates autophagy in pancreatic β-cells via the RAPGEF/EPAC-Ca2+-PPP3/calcineurin-TFEB axis. Autophagy 2021;:1-17. [PMID: 34338148 DOI: 10.1080/15548627.2021.1956123] [Reference Citation Analysis]
4 Graham GV, Conlon JM, Moffett RC, Abdel-Wahab YH, Flatt PR. Effects of long-acting analogues of lamprey GLP-1 and paddlefish glucagon on alpha- to beta-cell transdifferentiation in an insulin-deficient transgenic mouse model. J Pept Sci 2021;27:e3328. [PMID: 33843129 DOI: 10.1002/psc.3328] [Reference Citation Analysis]
5 Zhang Y, Whaley-Connell AT, Sowers JR, Ren J. Autophagy as an emerging target in cardiorenal metabolic disease: From pathophysiology to management. Pharmacol Ther 2018;191:1-22. [PMID: 29909238 DOI: 10.1016/j.pharmthera.2018.06.004] [Cited by in Crossref: 61] [Cited by in F6Publishing: 60] [Article Influence: 15.3] [Reference Citation Analysis]
6 Kanasaki K, Kawakita E, Koya D. Relevance of Autophagy Induction by Gastrointestinal Hormones: Focus on the Incretin-Based Drug Target and Glucagon. Front Pharmacol 2019;10:476. [PMID: 31156426 DOI: 10.3389/fphar.2019.00476] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
7 Reed J, Bain S, Kanamarlapudi V. Recent advances in understanding the role of glucagon-like peptide 1. F1000Res 2020;9:F1000 Faculty Rev-239. [PMID: 32269764 DOI: 10.12688/f1000research.20602.1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
8 Costes S, Bertrand G, Ravier MA. Mechanisms of Beta-Cell Apoptosis in Type 2 Diabetes-Prone Situations and Potential Protection by GLP-1-Based Therapies. Int J Mol Sci 2021;22:5303. [PMID: 34069914 DOI: 10.3390/ijms22105303] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Rowlands J, Heng J, Newsholme P, Carlessi R. Pleiotropic Effects of GLP-1 and Analogs on Cell Signaling, Metabolism, and Function. Front Endocrinol (Lausanne) 2018;9:672. [PMID: 30532733 DOI: 10.3389/fendo.2018.00672] [Cited by in Crossref: 67] [Cited by in F6Publishing: 63] [Article Influence: 16.8] [Reference Citation Analysis]
10 Li H, Donelan W, Wang F, Zhang P, Yang L, Ding Y, Tang D, Li S. GLP-1 Induces the Expression of FNDC5 Derivatives That Execute Lipolytic Actions. Front Cell Dev Biol 2021;9:777026. [PMID: 34869379 DOI: 10.3389/fcell.2021.777026] [Reference Citation Analysis]
11 Yao M, Zhang J, Li Z, Bai X, Ma J, Li Y. Liraglutide Protects Nucleus Pulposus Cells Against High-Glucose Induced Apoptosis by Activating PI3K/Akt/ mTOR/Caspase-3 and PI3K/Akt/GSK3β/Caspase-3 Signaling Pathways. Front Med (Lausanne) 2021;8:630962. [PMID: 33681258 DOI: 10.3389/fmed.2021.630962] [Cited by in F6Publishing: 1] [Reference Citation Analysis]